Metabolic & Endocrine Disease Summit (MEDS) Newsletter
Minimally Invasive Surgery Symposium (MISS)
Inaugural Medscape Cardiology Newsletter
Innovations in Dermatology Spring Conference
Innovations in Dermatology Newsletter
2nd Annual Perspectives in Lung Cancer Care
Acute Leukemia Forum 2022
Psychiatry Update Spring Conference
14th Annual T-cell Lymphoma Forum
Hematologic Malignancies Demystified
Innovations in Psychiatry Newsletter
There are no results under this Specialty.
Elevated COVID-19-related risks, many associated with comorbidities, emerged in a match-control study, whereas a systematic review delivers more encouraging news for people living with rheumatic disease.
Dr. Marcy B. Bolster addresses common patient concerns about bisphosphonate use.
Consider dose escalation and adding an immunomodulator to overcome the impact of antidrug antibodies in rheumatic disease patients.